Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome

Price, 1993, The repair of ionising radiation-induced damage to DNA, Semin Cancer Biol, 4, 61 Wang, 1985, DNA topoisomerases, Annu Rev Biochem, 54, 665, 10.1146/annurev.bi.54.070185.003313 Xu, 1998, Excision of C-4′-oxidized deoxyribose lesions from double-stranded DNA by human apurinic-apyrimidinic endonuclease (Ape 1 protein) and DNA polymerase beta, J Biol Chem, 273, 28837, 10.1074/jbc.273.44.28837 Robson, 1991, Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease) mutants, Nucl Acids Res, 19, 5519, 10.1093/nar/19.20.5519 Demple, 1991, Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease, Proc Natl Acad Sci U S A, 88, 11450, 10.1073/pnas.88.24.11450 Robson, 1992, Structure of the human DNA repair gene HAP1 and its localisation to chromosome 14q 11.2–12, Nucleic Acids Res, 20, 4417, 10.1093/nar/20.17.4417 Chen DS, Chen DJ, Demple B. Molecular basis for the radiosensitivity of two mouse mutant cell lines. In Abstracts of the 40th Annual Meeting of the Radiation Research Society, p. 21. 1992:15. Ono, 1995, Relationship between expression of a major apurinic/apyrimidinic endonuclease (APEX nuclease) and susceptibility to genotoxic agents in human glioma cell lines, J Neurooncol, 25, 183, 10.1007/BF01053151 Herring, 1998, Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers, Br J Cancer, 78, 1128, 10.1038/bjc.1998.641 Walker, 1994, A role of human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress, Nucleic Acids Res, 22, 4884, 10.1093/nar/22.23.4884 Yao, 1994, Activation of AP-1 and of nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia, Mol Cell Biol, 14, 5997, 10.1128/MCB.14.9.5997 Mueller-Klieser, 1982, Oxygen tensions in multicell spheroids of two cell lines, Br J Cancer, 45, 256, 10.1038/bjc.1982.41 Nordsmark, 1996, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head-and-neck, Radiother Oncol, 41, 31, 10.1016/S0167-8140(96)91811-3 Xanthoudakis, 1992, Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity, EMBO J, 11, 653, 10.1002/j.1460-2075.1992.tb05097.x Xanthoudakis, 1992, Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme, EMBO J, 11, 3324, 10.1002/j.1460-2075.1992.tb05411.x Jayaraman, 1997, Indentification of redox/repair protein Ref-1 as a potent activator of p53, Genes Dev, 11, 558, 10.1101/gad.11.5.558 Waldman, 1995, p21 is necessary for the p53-mediated G1 arrest in human cancer cells, Cancer Res, 55, 5187 Brugarolas, 1995, Radiation-induced cell cycle arrest compromised by p21 deficiency, Nature, 377, 552, 10.1038/377552a0 Kakolyris, 1998, Expression and subcellular localisation of human AP endonuclease 1 (HAP1/Ref-1) protein, Histopathology, 330, 561, 10.1046/j.1365-2559.1998.00541.x Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Mantel, 1966, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother Rep, 50, 163 Chadwick KH, Leenhouts HPL. The molecular theory of radiation biology. Springer-Verlag 1981:25–50. Herring, 1999, Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines, Br J Cancer, 80, 940, 10.1038/sj.bjc.6690447 Prieto-Alamo, 1999, Overexpression of the human HAP1 protein sensitizes cells to the lethal effect of bioreductive drugs, Carcinogenesis, 20, 415, 10.1093/carcin/20.3.415 LaBelle, 1984, DNA repair in cultured mouse cells of increasing population doubling level, Mut Res, 132, 51 Chen, 1991, Two distinct human DNA diesterases that hydrolyze 3′-blocking deoxyribose fragments from oxidized DNA, Nucleic Acid Res, 19, 507, 10.1093/nar/19.21.5907 Kakolyris, 1997, Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence, Cancer Res, 57, 1794 Kakolyris S, Giatromanolaki A, Koukourakis MI, Gatter KC, Harris AL. Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non small cell lung cancer. J Pathol 1999; in press Slevin, 1999, The potential benefit from individualised radiotherapy scheduling for head-and-neck tumours on the basis of both histological grade and kinetics, Radiother Oncol, 51, 109 Kakolyris, 1998, Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis, Br J Cancer, 77, 1169, 10.1038/bjc.1998.194 Taniguchi, 1989, High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line, Cancer Res, 49, 6738 Lamb, 1997, AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44, Mol Cell Biol, 17, 963, 10.1128/MCB.17.2.963 Mineta, 1998, p53 mutation, but not p53 overexpression, correlates with survival in head-and-neck squamous cell carcinoma, Br J Cancer, 78, 1084, 10.1038/bjc.1998.632 Jayaraman, 1997, Identification of redox/repair protein Ref-1 as apotent activator of p53, Gen Dev, 11, 556, 10.1101/gad.11.5.558 Meira, 1997, Genetic interaction between HAP1/REF-1 and p53, Nat Med, 17, 145, 10.1038/ng1097-145 Chadwick KH, Leenhouts HP. The molecular theory of radiation biology. Monographs on theoretical and applied genetics 5. Sringer-Verlag eds. 1981. Murray, 1999, A survey of the sequence-specific interaction of damaging agents with DNA, Prog Nucleic Acid Res Mol Biol, 63, 367, 10.1016/S0079-6603(08)60727-8 Gong, 1999, The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage, Nature, 399, 806, 10.1038/21690 Low, 1994, p53 status and the efficacy of cancer therapy in vivo, Science, 266, 807, 10.1126/science.7973635 Tada, 1998, Selective sensitivity of cerebral glioblastomas harboring p53 mutations, Cancer Res, 58, 1793